Study on the Effect of Natural Wind on the Smoke Spread Law of Extra-Long Tunnel Fires with Inclined Shafts for Air Supply and Exhaust

High-temperature smoke generated by tunnel fires is the most important factor causing casualties. To explore the influence of natural wind on fire smoke movement in an extra-long highway tunnel based on the Taihang Mountain Tunnel, the distribution law of natural wind in the tunnel was obtained by on-site monitoring of the meteorological conditions at the tunnel site. A three-dimensional fire dynamics tunnel model considering an inclined shaft smoke exhaust was established, and the influence of natural wind on tunnel temperature distribution, smoke spread and smoke exhaust efficiency was studied. The results show that the natural wind speed of the Taihang Mountain Tunnel is mainly concentrated at 0~3 m/s. The main wind direction of the natural wind on the left tunnel is opposite to the driving direction, and the distribution probability of the main wind direction in each section is 81.27% and 72.15%, respectively. The main wind direction of the right tunnel is the same as the driving direction, and the distribution probability of the main wind direction in each section is 56.78%, 69.73%, 67.32% and 64.65%, respectively. The negative natural wind can inhibit the smoke spread downstream of the smoke exhaust port, but it is not conducive to the smoke exhaust. The positive natural wind promotes the smoke spread to the downstream of the smoke exhaust port, and the larger the natural wind speed, the longer the spread length. Natural wind reduces the smoke exhaust efficiency. For positive or negative natural wind with a guaranteed rate of 70%, the smoke exhaust efficiency is reduced by 27.76% and 15.59%, respectively, compared with the condition without natural wind. The research results can provide a useful reference for the design of fire smoke exhausts and smoke control schemes in extra-long highway tunnels

Microstructure evolution during oxidation of quinary Ti3(AlSiSn)C2 at high temperatures and induced probable performance

Quinary Ti3Al0.6Si0.2Sn0.2C2 and Ti3Al0.5Si0.4Sn0.1C2 solid solution bulks were synthesized via hot-pressing process. High temperature oxidation behaviors were then investigated over a temperature range of 800–1200 °C. The weight gain per surface area and oxidation layer thickness were measured to study the oxidation kinetics. The as-synthesized compounds with varying solid solution ingredients exhibited comparable oxidation kinetics which fitted a parabolic kinetic better with the oxidation duration of 0–20 h, while it appeared to get more complicated after prolonging the oxidation time. The microstructure evolution and phase compositions of the oxide scales during breakaway oxidation were characterized to illuminate the oxidation mechanism. The oxidation layers exhibited a multi-layer structure resulting from the disparities between the diffusion and migration energies of the multi-elements. Anticipated performance induced by high temperature oxidation was further explored through investigation on the crack self-healing and tribological optimization capacities. It was revealed that cracks could be filled by predominant TiO2 and Al2O3 with a high efficiency at 1000 °C during annealing in air. At 800 °C, Ti3Al0.6Si0.2Sn0.2C2 exhibited self-lubricating properties that was attributed to the formation of smoothing tribo-oxide films, as demonstrated by the increasing oxygen content of the friction surface during sliding

Image2_A novel cuproptosis-related lncRNA signature predicts prognosis and therapeutic response in bladder cancer.PNG

Bladder cancer (BC) ranks the tenth in the incidence of global tumor epidemiology. LncRNAs and cuproptosis were discovered to regulate the cell death. Herein, we downloaded transcriptome profiling, mutational data, and clinical data on patients from The Cancer Genome Atlas (TCGA). High- and low-risk BC patients were categorized. Three CRLs (AL590428.1, AL138756.1 and GUSBP11) were taken into prognostic signature through least absolute shrinkage and selection operator (LASSO) Cox regression. Worse OS and PFS were shown in high-risk group (p < 0.05). ROC, independent prognostic analyses, nomogram and C-index were predicted via CRLs. Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) analysis indicated IncRNAs play a biological role in BC progression. Immune-related functions showed the high-risk group received more benefit from immunotherapy and had stronger immune responses, and the overall survival was better (p < 0.05). Finally, a more effective outcome (p < 0.05) was found from clinical immunotherapy via the TIDE algorithm and many potential anti-tumor drugs were identified. In our study, the cuproptosis-related signature provided a novel tool to predict the prognosis in BC patients accurately and provided a novel strategy for clinical immunotherapy and clinical applications.</p

Table3_A novel cuproptosis-related lncRNA signature predicts prognosis and therapeutic response in bladder cancer.XLSX

Bladder cancer (BC) ranks the tenth in the incidence of global tumor epidemiology. LncRNAs and cuproptosis were discovered to regulate the cell death. Herein, we downloaded transcriptome profiling, mutational data, and clinical data on patients from The Cancer Genome Atlas (TCGA). High- and low-risk BC patients were categorized. Three CRLs (AL590428.1, AL138756.1 and GUSBP11) were taken into prognostic signature through least absolute shrinkage and selection operator (LASSO) Cox regression. Worse OS and PFS were shown in high-risk group (p < 0.05). ROC, independent prognostic analyses, nomogram and C-index were predicted via CRLs. Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) analysis indicated IncRNAs play a biological role in BC progression. Immune-related functions showed the high-risk group received more benefit from immunotherapy and had stronger immune responses, and the overall survival was better (p < 0.05). Finally, a more effective outcome (p < 0.05) was found from clinical immunotherapy via the TIDE algorithm and many potential anti-tumor drugs were identified. In our study, the cuproptosis-related signature provided a novel tool to predict the prognosis in BC patients accurately and provided a novel strategy for clinical immunotherapy and clinical applications.</p

Table1_A novel cuproptosis-related lncRNA signature predicts prognosis and therapeutic response in bladder cancer.XLSX

Bladder cancer (BC) ranks the tenth in the incidence of global tumor epidemiology. LncRNAs and cuproptosis were discovered to regulate the cell death. Herein, we downloaded transcriptome profiling, mutational data, and clinical data on patients from The Cancer Genome Atlas (TCGA). High- and low-risk BC patients were categorized. Three CRLs (AL590428.1, AL138756.1 and GUSBP11) were taken into prognostic signature through least absolute shrinkage and selection operator (LASSO) Cox regression. Worse OS and PFS were shown in high-risk group (p < 0.05). ROC, independent prognostic analyses, nomogram and C-index were predicted via CRLs. Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) analysis indicated IncRNAs play a biological role in BC progression. Immune-related functions showed the high-risk group received more benefit from immunotherapy and had stronger immune responses, and the overall survival was better (p < 0.05). Finally, a more effective outcome (p < 0.05) was found from clinical immunotherapy via the TIDE algorithm and many potential anti-tumor drugs were identified. In our study, the cuproptosis-related signature provided a novel tool to predict the prognosis in BC patients accurately and provided a novel strategy for clinical immunotherapy and clinical applications.</p

Table2_A novel cuproptosis-related lncRNA signature predicts prognosis and therapeutic response in bladder cancer.XLSX

Bladder cancer (BC) ranks the tenth in the incidence of global tumor epidemiology. LncRNAs and cuproptosis were discovered to regulate the cell death. Herein, we downloaded transcriptome profiling, mutational data, and clinical data on patients from The Cancer Genome Atlas (TCGA). High- and low-risk BC patients were categorized. Three CRLs (AL590428.1, AL138756.1 and GUSBP11) were taken into prognostic signature through least absolute shrinkage and selection operator (LASSO) Cox regression. Worse OS and PFS were shown in high-risk group (p < 0.05). ROC, independent prognostic analyses, nomogram and C-index were predicted via CRLs. Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) analysis indicated IncRNAs play a biological role in BC progression. Immune-related functions showed the high-risk group received more benefit from immunotherapy and had stronger immune responses, and the overall survival was better (p < 0.05). Finally, a more effective outcome (p < 0.05) was found from clinical immunotherapy via the TIDE algorithm and many potential anti-tumor drugs were identified. In our study, the cuproptosis-related signature provided a novel tool to predict the prognosis in BC patients accurately and provided a novel strategy for clinical immunotherapy and clinical applications.</p

Image1_A novel cuproptosis-related lncRNA signature predicts prognosis and therapeutic response in bladder cancer.PNG

Bladder cancer (BC) ranks the tenth in the incidence of global tumor epidemiology. LncRNAs and cuproptosis were discovered to regulate the cell death. Herein, we downloaded transcriptome profiling, mutational data, and clinical data on patients from The Cancer Genome Atlas (TCGA). High- and low-risk BC patients were categorized. Three CRLs (AL590428.1, AL138756.1 and GUSBP11) were taken into prognostic signature through least absolute shrinkage and selection operator (LASSO) Cox regression. Worse OS and PFS were shown in high-risk group (p < 0.05). ROC, independent prognostic analyses, nomogram and C-index were predicted via CRLs. Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) analysis indicated IncRNAs play a biological role in BC progression. Immune-related functions showed the high-risk group received more benefit from immunotherapy and had stronger immune responses, and the overall survival was better (p < 0.05). Finally, a more effective outcome (p < 0.05) was found from clinical immunotherapy via the TIDE algorithm and many potential anti-tumor drugs were identified. In our study, the cuproptosis-related signature provided a novel tool to predict the prognosis in BC patients accurately and provided a novel strategy for clinical immunotherapy and clinical applications.</p